Prostate Specific Antigen (PSA) Testing Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Prostate specific antigen market
Prostate Specific Antigen (PSA) Testing Market: By Type (Free Prostate Specific Antigen Test, Complex Prostate Specific Antigen Test, Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test); By Assays (Radioimmunoassay, Enzyme Immunoassay); By Geography - Forecast(2018-2023)
Report Code : HCR 0038
Updated Date: 01 June, 2018  
5

Copies sold

    Client Rating

1. Prostate Specific Antigen Testing Market Overview
2. Prostate Specific Antigen Testing Market Executive Summary
3. PSA Testing Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End user profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. PSA Testing Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. PSA Testing Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Opportunities Analysis
   5.3. Product/Market Life Cycle Analysis
6. PSA Testing Market – By Test
   6.1. Free Prostate Specific Antigen Test
   6.2. Complex Prostate Specific Antigen Test
   6.3. Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test
7. PSA Testing Market – By Assays
   7.1. Radioimmunoassay (RIA)
   7.2. Enzyme Immunoassays (EIA)
8. Global PSA Testing Market - Geographic Analysis
   8.1. North America 
      8.1.1. U.S. 
      8.1.2. Canada 
      8.1.3. Mexico 
      8.1.4. Rest of North America
   8.2. South America 
      8.2.1. Brazil 
      8.2.2. Venezuela
      8.2.3. Argentina
      8.2.4. Ecuador
      8.2.5. Peru
      8.2.6. Colombia 
      8.2.7. Costa Rica
      8.2.8. Rest of South America
   8.3. Europe 
      8.3.1. U.K 
      8.3.2. Germany 
      8.3.3. Italy 
      8.3.4. France
      8.3.5. Netherlands
      8.3.6. Belgium
      8.3.7. Spain
      8.3.8. Rest of Europe
   8.4. APAC
      8.4.1. China 
      8.4.2. Australia 
      8.4.3. South Korea
      8.4.4. India
      8.4.5. Taiwan
      8.4.6. Malaysia
      8.4.7. Rest of APAC
   8.5. Middle East & Africa 
      8.5.1. Israel
      8.5.2. Saudi Arabia
      8.5.3. South Africa
      8.5.4. Rest of Middle East & Africa
   8.6. Other
9. PSA testing – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles
   10.1. Abbott Laboratories, Inc.
   10.2. Bayer AG
   10.3. Beckman Coulter, Inc.
   10.4. GE Healthcare
   10.5. GlaxoSmithKline, plc.
   10.6. Novartis Pharma AG
   10.7. UroLogix
   10.8. Bristol - Myers Squibb Company
   10.9. AstraZeneca plc.
   10.10. Johnson & Johnson Diagnostics
   10.11. Company 11
   10.12. Company 12
   10.13. Company 13
   10.14. Company 14
   10.15. Company 15
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll